首页> 外文期刊>American Journal of Physiology >Evidence for altered ETB receptor characteristics during development and progression of ventricular cardiomyocyte hypertrophy.
【24h】

Evidence for altered ETB receptor characteristics during development and progression of ventricular cardiomyocyte hypertrophy.

机译:在心室心肌细胞肥大的发生和发展过程中,ETB受体特征发生改变的证据。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The hypothesis that endothelin (ET) receptor mechanisms are altered during development and progression of left ventricular hypertrophy (LVH) in vivo was tested using spontaneously hypertensive rats (SHRs). Ventricular cardiomyocytes were isolated from SHRs before onset (8 and 12 wk) and during progression (16, 20, and 24 wk) of LVH and compared with age-matched normotensive Wistar-Kyoto (WKY) rats. PreproET-1 mRNA expression was elevated in SHR (P < 0.05) relative to WKY cardiomyocytes at 20-24 wk. ET binding-site density was twofold greater in SHR than WKY cells at 12 wk (P < 0.05) but normalized at 20 wk. ET(B) receptors were detected on SHR cardiomyocytes as early as 8 wk and their affinity increased progressively with age (P < 0.05), whereas ET(B) receptors were not detected on WKY cells until 20 wk. ET-1 stimulated protein synthesis with similar maximum responses between strains (21-30%), in contrast with sarafotoxin 6c, which stimulated protein synthesis in SHR (13-20%) but not WKY cells at 12-20wk. In SHR but not WKY cells, the ET(B) receptor-selective ligand A-192621 increased protein synthesis progressively with the development of LVH (15% maximum effect). In conclusion, the presence of ET(B) receptors (8-12 wk) coupled with functional responsiveness of SHR cells but not WKY cells to sarafotoxin 6c at 12 wk supports the involvement of ET(B) receptors before the onset of cardiomyocyte hypertrophy, whereas altered ET(B) receptor characteristics during active hypertrophy (16-24 wk) indicate that ET(B) receptor mechanisms may also contribute to disease progression.
机译:使用自发性高血压大鼠(SHRs),测试了内皮素(ET)受体机制在体内左心室肥大(LVH)的发生和发展过程中发生改变的假说。在LVH发作之前(8周和12周)和进展期间(16周,20周和24周),从SHR中分离出心室心肌细胞,并与年龄匹配的血压正常的Wistar-Kyoto(WKY)大鼠进行比较。相对于WKY心肌细胞,在20-24 wk时SHR中PreproET-1 mRNA表达升高(P <0.05)。在12周时,SHR中的ET结合位点密度是WKY细胞的两倍(P <0.05),但在20周时归一化。早在8周时就在SHR心肌细胞上检测到ET(B)受体,并且它们的亲和力随年龄增长而逐渐增加(P <0.05),而直到20周时才在WKY细胞上检测到ET(B)受体。与sarafotoxin 6c相比,ET-1刺激了菌株之间具有最大响应的蛋白质合成(21-30%),而sarafotoxin 6c则刺激了SHR中的蛋白质合成(13-20%),但在12-20wk时未刺激WKY细胞。在SHR而非WKY细胞中,随着LVH的发展,ET(B)受体选择性配体A-192621逐渐增加了蛋白质的合成(最大作用为15%)。总之,ET(B)受体(8-12 wk)的存在与SHR细胞(而非WKY细胞)在12 wk时对sarafotoxin 6c的功能反应相结合,支持ET(B)受体在心肌肥大发作之前参与,而活动性肥大(16-24 wk)期间ET(B)受体特征的改变表明ET(B)受体机制也可能有助于疾病进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号